#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epilepsy with myoclonic-atonic seizures Thalassaemia beta Fibrodysplasia ossificans progressiva Desmoplastic small round cell tumour Factor IX deficiency Glomerulonephritis acute Adrenocortical carcinoma Small intestine leiomyosarcoma Hypoparathyroidism Neuroblastoma Mitochondrial myopathy Pouchitis Vernal keratoconjunctivitis Chronic graft versus host disease in liver Juvenile psoriatic arthritis More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Treatment Chondrosarcoma – Treatment Malignant fibrous histiocytoma – Basic Information Factor IX deficiency Familial haemophagocytic lymphohistiocytosis – Trials in Disease Idiopathic pulmonary fibrosis – Life with Disease Osteosarcoma – Trials in Disease Ewing’s sarcoma recurrent Isodicentric chromosome 15 syndrome – Basic Information Progressive supranuclear palsy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sym025 Aliskiren Mps-102 Gsk3915393 Anv600 Melatonin Elacestrant Ivacaftor Zasocitinib Topotecan Idecabtagene Vicleucel Cldn6 Car-T Folic Acid SC0062 Cedazuridine Hydroxypropyl Cellulose Lf Cabotegravir Dexpanthenol [18F]Mc225 Naloxone Hydrochloride More therapies…

    Learn about Your Condition

    Hodgkin's disease refractory Caesarean section Facial paresis Lichen planopilaris Cryoglobulinaemia Mental disorder Substance use disorder Peripheral artery stenosis Langerhans' cell histiocytosis Anogenital warts Cancer pain Endometrial adenocarcinoma Mite allergy Mitochondrial DNA depletion Chronic kidney disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Ibrutinib
    Italy

  • Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    • Prostate cancer
    Investigated Drugs:
    • Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)
    • Fludrocortisone Acetate
    • Hydrocortisone Acetate
    Denmark Finland France Germany Ireland Italy +2

  • Study on the Safety and Effectiveness of Isatuximab and Drug Combination for Adults with Relapsed or Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Isatuximab
    • Bortezomib
    • Cyclophosphamide
    Germany

  • Study on the Effectiveness of Oral Antibiotics Gentamicin and Metronidazole in Patients with Acute Mesenteric Ischemia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Intestinal ischaemia
    Investigated Drugs:
    • Gentamicin
    • Metronidazole
    • Sodium Chloride
    France

  • Study of Posaconazole for Preventing Fungal Infections in Patients Receiving Stem Cell Transplants for Blood Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Posaconazole
    France

  • Study on Dexamethasone for Patients with Advanced Relapsed or Refractory Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone
    France
Previous Page
1 … 319 320 321 322 323 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!